Xcout Intel
Adaptam Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Adaptam Therapeutics among biotechnology companies — ranked by similarity to what Adaptam Therapeutics actually does, not by market-cap band.
Subscribe to see Adaptam Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Adaptam Therapeutics
Adaptam Therapeutics is an oncology-focused immunotherapy company headquartered in San Sebastián, Basque Country, Spain, developing therapies that target immunosuppressive myeloid tumors.
Adaptam Therapeutics at a glance
Adaptam Therapeutics is a biotechnology company headquartered in Spain. Its most recent funding round, Pre-Seed, raised $3.2M in November 2025. Xcout tracks 4 named people at Adaptam Therapeutics, including Pablo Cironi (Chairman).
Adaptam Therapeutics leadership
- Pablo CironiChairman
- Asis PalazonCEO/CSO Founder
- José M MatoBoard Member
- Salvatore CappadonaBoard Member
Adaptam Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $3.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Adaptam Therapeutics competitors
Ranked by semantic similarity — how close each company is to Adaptam Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Indapta Therapeutics, Inc. is a privately held biotechnology company founded in 2017 and headquartered in San Francisco, California. The company is focused on developing an innovative natural killer (NK) cell therapy platform primarily intended for treating myeloma and other diseases.
Similar biotechnology company
Avammune Therapeutics is an R&D-driven drug discovery company headquartered in Philadelphia, Pennsylvania. The company focuses on developing novel, modality-agnostic immunotherapies and cancer therapies to address high unmet medical needs in hard-to-treat solid tumors.
Similar biotechnology company
Oncomatryx is a Spanish biopharmaceutical company headquartered in Derio, Basque Country, Spain. The firm pioneers targeted oncology therapeutics aimed at treating metastatic solid tumors and utilizes advanced computational approaches in its drug discovery pipeline.
Biotech
Adaptin Bio is a biotechnology company developing a proprietary drug delivery platform designed to enhance the transfer of therapeutics across biological barriers into the brain and other targeted tissues. Its lead technology, the Brain Bispecific T cell Engager (BRiTE) platform, manipulates the human immune system to target diseases in oncology, central nervous system disorders, autoimmune conditions, and cardiovascular markets.
Biotech
OSE Immunotherapeutics is a clinical-stage biotechnology company that develops innovative immunotherapies for immune activation and regulation in immuno-oncology and immuno-inflammation. The company utilizes proprietary research platforms and a portfolio of clinical-stage assets to provide therapeutic options for patients.
Similar biotechnology company
ImmunOs Therapeutics AG is a biotechnology company that develops treatments for cancer and inflammatory diseases by harnessing the human immune system. The company focuses on immuno-oncology and autoimmune therapies through a dedicated drug pipeline.
Similar biotechnology company
OneChain Immunotherapeutics is a biotechnology company based in Barcelona focused on the development of CAR-T cell therapies and in vivo platforms for cancer immunotherapy.
Similar biotechnology company
Immunomic Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company founded in 2005 and headquartered in Rockville, Maryland, that develops innovative immune therapies.
Similar biotechnology company
Aptevo Therapeutics Inc. is a public, clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for immuno-oncology.
Similar biotechnology company
Affimed Therapeutics is a biotechnology company focused on developing cancer immunotherapies that recruit and activate innate immune cells, particularly natural killer (NK) cells, to attack tumor cells. Its investigational products are intended for oncology patients and are developed for use by cancer-care providers.
Similar biotechnology company
Grey Wolf Therapeutics is a biotechnology company headquartered in the UK focused on delivering a new class of treatments to improve the lives of people with cancers and autoimmune disorders.
Similar biotechnology company
iOmx Therapeutics AG is a biopharmaceutical company located in Martinsried near Munich, Germany, dedicated to discovering and developing next-generation targeted cancer immunotherapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Adaptam Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Adaptam Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →